Role of technetium-99m sestamibi scintimammography and contrast-enhanced magnetic resonance imaging for the evaluation of indeterminate mammograms

European Journal of Nuclear Medicine

Volumn 24, Issue 10, 1997, Pages 1221-1229

  Tiling, Reinhold ^a   Khalkhali, Iraj ^b   Sommer, Harald ^a   Moser, Ruth ^a   Meyer, Gabriele ^a   Willemsen, Fritz ^a   Pfluger, Thomas ^a   Tatsch, Klaus ^a   Hahn, Klaus ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Breast carcinoma; Contrast enhanced magnetic resonance imaging; Technetium 99m sestamibi scintimammography

Indexed keywords

GADOLINIUM; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER SCINTISCANNING; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING;

BREAST DISEASES; BREAST NEOPLASMS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 0030690344     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050145     Document Type: Article

References (36)

1. American Cancer Society. Cancer facts and figures. Atlanta, Ga.: American Cancer Society, 1992.
2. Ries LAG, Hankey BF, Miller BA, Hartman AM, Edwards BK. Cancer statistics review. J Natl Cancer Inst 1991; 91: 2780P.
3. Sickles EA. Mammographic features of 300 consecutive non-palpable breast cancers. Am J Roentgenol 1986; 146: 661-663.
4. Bird RE, Wallace TW, Yankanskas BC. Analysis of cancer missed at the screening mammography. Radiology 1992; 184: 613-617.
5. Jackson VP, Hendrick RE, Kerg SA, et al. Imaging of the radiographically dense breast. Radiology 1993; 198: 297-301.
6. Kopans DB. The positive predictive value of mammography. Am J Roentgenol 1992; 158: 521-526.
7. Kopans DB. Breast imaging. Philadelphia: J.B. Lippincott; 1989: p 320
8. Adler DD, Wahl RL. New methods for imaging the breast: techniques, findings, and potential. Am J Roentgenol 1995; 164: 19-30.
9. Harms SE, Flamig DP, Evans WP, Harries SA, Bown S. MR imaging of the breast: current status and future potential. Am J Roentgenol 1994; 163: 1039-1047.
10. Orel SG, Schnall MD, Powell CM, et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 1995; 196: 115-122
11. Weinreb JC, Newstead G. MR imaging of the breast. Radiology 1995; 196: 593-610.
12. 99mTc-MIBI: a comparative study with mammography and ultrasonography. Nucl Med Commun 1994; 15: 604-612.
13. Khalkhali I, Mena I, Diggles L. Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m sestamibi. Eur J Nucl Med 1994; 21: 357-362.
14. Khalkhali I, Cutrone J, Mena I, et al. Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radiology 1995; 196: 421-426.
15. Khalkhali I, Cutrone J, Mena I, et al. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up. J Nucl Med 1995; 36: 1784-1789.
16. Palmedo H, Schomburg A, Grünwald F, Mallmann P, Krebs D, Biersack HJ. Technetium-99m-MIBI scintimammography for suspicious breast lesions. J Nucl Med 1996; 37: 626-630.
17. Taillefer R, Robidoux A, Lambert R, Turpin S, Laperriere J. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995; 36: 1758-1765.
18. Tiling R, Sommer H, Pechmann M, et al. Comparison of Tc-99m sestamibi scintimammography with contrast enhanced MRI for the diagnosis of breast lesions. J Nucl Med 1997; 38: 58-62.
19. Waxman A, Nagaraj N, Ashok G, et al. Sensitivity and specificity of Tc-99m methoxy isobutyl isonitrile (MIBI) in the evaluation of primary carcinoma of the breast: comparison of palpable and non-palpable lesions with mammography [abstract]. J Nucl Med 1994; 35: 22.
20. Heywang-Köbrunner SH. Contrast-enhanced magnetic resonance imaging of the breast. Invest Radiol 1994; 29: 94-104.
21. Fobben ES, Rubin CZ, Kalisher L, Dembner AG, Seltzer MH, Santoro EJ. Breast MR imaging with commercially available techniques: radiologic-pathologic correlation. Radiology 1995; 196: 143-152.
22. Stelling CB. Breast cancer staging with contrast material-enhanced MR imaging: should it change patient treatment? Radiology 1995; 196: 16-18.
23. Humphry LL, Ballard DJ. Early detection of breast cancer in women. Prev Pract 1989; 16: 115-132.
24. Harms SE, Flamig DP, Hesley KL, et al. MR imaging of the breast with rotating delivery of excitation of resonance: clinical experience with pathologic correlation. Radiology 1993; 187: 493-501.
25. Lewis-Jones HG, Whitehouse GH, Leinster SJ. The role of MRI in the assessment of local recurrent breast carcinoma. Clin Radiol 1991; 43: 197-204.
26. Heywang SH, Hilbertz T, Beck R, et al. Contrast-material enhanced MRI of the breast in patients with postoperative scarring and silicon implants. J Comput Assist Tomogr 1990; 14: 348-356.
27. Heywang-Köbrunner SH, Schlegel A, Beck R, et al. Contrast-enhanced MRI of the breast after limited surgery and radiation therapy. J Comput Assist Tomogr 1993; 17: 891-900.
28. Wiener JI, Chako AC, Merten CW, et al. Breast and axillary tissue MR imaging: correlations of signal intensities and relaxation times with pathologic findings. Radiology 1986; 160: 299-305.
29. Alcorn FS, Turner DA, Clark JW, et al. Magnetic resonance imaging in the study of the breast. Radiographics 1985; 5: 631-652.
30. Revel D, Brasch R, Paajanen H, et al. Gd-DTPA contrast enhancement and tissue differentiation in MR imaging of experimental breast carcinoma. Radiology 1986; 158: 319-323.
31. Orel SG, Schnall MD, Livolsi VA, Troupin RH. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology 1994; 190: 485-493.
32. Heywang SA, Wolf A, Pruss E, et al. MR imaging of the breast with Gd-DTPA: use and limitations. Radiology 1989; 171: 95-103.
33. Carvalho PA, Chiu ML, Kronaug JF, et al. Subcellular distribution and analysis of Tc-99m MIBI in isolated perfused rat hearts. J Nucl Med 1992; 33: 1516-1521.
34. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (I) in cultured mouse fibroblast. J Nucl Med 1990; 31: 1646-1653.
35. Piwnica-Worms D, Holman BL. Noncardiac applications of hexakis (alkylisonitrile) technetium-99m complexes. J Nucl Med 1989; 31: 1166-1167.
36. Palmedo H, Grünwald F, Bender H, Schomburg A, Mallmann P, Krebs D, Biersack HJ. Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging. Eur J Nucl Med 1996; 23: 940-946.